JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3176
Establishment Labs
ESTA
$1.91B
| $2.6M | ﹤0.01% |
47,752
+41,509
| +665% | +$2.64M |
2021 Q2
4 quarters
|
|
3177
Kyndryl
KD
$2.52B
| $2.59M | ﹤0.01% |
265,288
-3,408,009
| -93% | -$39.7M |
2021 Q4
2 quarters
|
|
3178
CALL
Cigna
CI
$71.5B
| $2.58M | ﹤0.01% |
9,800
-8,900
| -48% | -$2.29M |
2021 Q2
4 quarters
|
|
3179
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$333M
| $2.57M | ﹤0.01% |
33,875
+12,277
| +57% | +$1.02M |
2018 Q2
16 quarters
|
|
3180
PUT
Union Pacific
UNP
$165B
| $2.56M | ﹤0.01% |
12,000
-300,500
| -96% | -$68.4M |
2014 Q3
31 quarters
|
|
3181
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.55B
| $2.56M | ﹤0.01% |
33,589
-5,430
| -14% | -$449K |
2013 Q2
36 quarters
|
|
3182
MarineMax
HZO
$1.16B
| $2.56M | ﹤0.01% |
70,719
-29,181
| -29% | -$1.17M |
2017 Q4
18 quarters
|
|
3183
Simulations Plus
SLP
$374M
| $2.55M | ﹤0.01% |
51,715
+284
| +0.6% | +$13.4K |
2017 Q4
18 quarters
|
|
|
SI
3184
DELISTED
Silvergate Capital Corporation
SI
| $2.55M | ﹤0.01% |
47,647
+18,053
| +61% | +$1.68M |
2019 Q4
10 quarters
|
|
3185
Immunovant
IMVT
$6.94B
| $2.55M | ﹤0.01% |
653,181
+191,599
| +42% | +$828K |
2020 Q1
9 quarters
|
|
3186
Piper Sandler
PIPR
$4.62B
| $2.55M | ﹤0.01% |
89,908
-264,840
| -75% | -$8M |
2013 Q2
36 quarters
|
|
3187
PUT
Carnival Corporation Ltd
CCL
$34.6B
| $2.55M | ﹤0.01% |
294,400
-260,000
| -47% | -$3.82M |
2020 Q2
8 quarters
|
|
3188
CALL
EQT Corp
EQT
$31.4B
| $2.54M | ﹤0.01% |
73,900
-1,584,900
| -96% | -$65.3M |
2020 Q3
7 quarters
|
|
3189
PUT
Targa Resources
TRGP
$60.4B
| $2.54M | ﹤0.01% |
+42,500
| New | +$3.05M |
2022 Q2
0 quarters
|
|
|
VRAY
3190
DELISTED
ViewRay, Inc.
VRAY
| $2.54M | ﹤0.01% |
956,733
-13,499
| -1% | -$40.6K |
2016 Q4
22 quarters
|
|
3191
Nektar Therapeutics
NKTR
$1.49B
| $2.53M | ﹤0.01% |
44,438
+32,262
| +265% | +$2.04M |
2013 Q2
36 quarters
|
|
|
MEOA
3192
DELISTED
Minority Equality Opportunities Acquisition Inc. Class A Common Stock
MEOA
| $2.53M | ﹤0.01% |
+250,000
| New | +$2.52M |
2022 Q2
0 quarters
|
|
3193
CALL
VanEck Gold Miners ETF
GDX
$26.1B
| $2.53M | ﹤0.01% |
35,800
-301,500
| -89% | -$10.2M |
2016 Q3
23 quarters
|
|
3194
MGP Ingredients
MGPI
$274M
| $2.53M | ﹤0.01% |
25,244
-19,344
| -43% | -$1.82M |
2016 Q3
23 quarters
|
|
3195
CALL
Ciena
CIEN
$55.5B
| $2.52M | ﹤0.01% |
55,200
+28,900
| +110% | +$1.5M |
2022 Q1
1 quarter
|
|
|
GSD
3196
DELISTED
Global Systems Dynamics Inc. Class A Common Stock
GSD
| $2.52M | ﹤0.01% |
+250,000
| New | +$2.52M |
2022 Q2
0 quarters
|
|
3197
IAMGOLD
IAG
$10.6B
| $2.52M | ﹤0.01% |
1,562,688
-868,175
| -36% | -$2.18M |
2021 Q4
2 quarters
|
|
3198
Invesco China Technology ETF
CQQQ
$2.5B
| $2.51M | ﹤0.01% |
49,766
+12,440
| +33% | +$561K |
2020 Q3
7 quarters
|
|
|
FPI
3199
Farmland Partners
FPI
$490M
| $2.51M | ﹤0.01% |
182,039
+121,556
| +201% | +$1.77M |
2016 Q1
25 quarters
|
|
3200
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$817M
| $2.51M | ﹤0.01% |
227,289
| – | – |
2019 Q4
10 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.